Moors & Cabot, Inc. Viatris Inc Transaction History
Moors & Cabot, Inc.
- $2.05 Billion
- Q2 2025
A detailed history of Moors & Cabot, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Moors & Cabot, Inc. holds 15,020 shares of VTRS stock, worth $152,152. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,020
Previous 16,020
6.24%
Holding current value
$152,152
Previous $139,000
3.6%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding VTRS
# of Institutions
1,129Shares Held
986MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$939 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$798 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$672 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$560 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...